Health
Newly approved drugs in Canada lack key pediatric drug information – News-Medical.Net
Newly approved drugs in Canada lack important pediatric drug information in their product monograph, according to an analysis led by McMaster University and McMaster Children’s Hospital.
Reviewed by Emily Henderson, B.Sc.Sep 1 2020
Newly approved drugs in Canada lack important pediatric drug information in their product monograph, according to an analysis led by McMaster University and McMaster Children’s Hospital.
This absence of pediatric information perpetuates “off-label” drug use which could be dangerous for this vulnerable population, say the authors. They add that Canadian regulatory mechanisms are needed to ensure submission of pediatric data by manufacturers when use …
-
Noosa News21 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Business22 hours agoASX 200 lifts on the RBA’s latest interest rate call
-
General18 hours agoDeath of 86-year-old driver in Karoonda Highway crash prompts push for change
-
General14 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people